New Enterprise Associates 16, L.P. Insider Trades

Insider Trading History

Track insider trading activity for New Enterprise Associates 16, L.P.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
NeueHealth
NeueHealth NEUE
10% owner
Holding Value $2.51M 372,255 shares
Last Trade
Oct 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.51M 372,255 shares
$6.75
$6.75
NeueHealth
NeueHealth NEUE
10% owner
Holding Value $5.32M 788,259 shares
Last Trade
Oct 02, 2025 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$1.28M 189,195 shares
$6.75
$6.75
NeueHealth
NeueHealth NEUE
10% owner
Holding Value $0 0 shares
Last Trade
Oct 02, 2025 Sale (In The Money)Reported as In The Money on SEC Form 4.
$1.28M 189,195 shares
$6.75
$6.75
NeueHealth
NeueHealth NEUE
10% owner
Holding Value $0 0 shares
Last Trade
Oct 02, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$7.83M 1,159,683 shares
$6.75
$6.75
NeueHealth
NeueHealth NEUE
10% owner
Holding Value $7.84M 1,160,234 shares
Last Trade
Oct 02, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.51M 372,255 shares
$6.75
$6.75
NeueHealth
NeueHealth NEUE
10% owner
Holding Value $7.83M 1,159,683 shares
Last Trade
Oct 02, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$3.72k 551 shares
$6.75
$6.75
NeueHealth
NeueHealth NEUE
10% owner
Holding Value $5.32M 787,979 shares
Last Trade
Oct 02, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.89k 280 shares
$6.75
$6.75
NeueHealth
NeueHealth NEUE
10% owner
Holding Value $0 0 shares
Last Trade
Oct 02, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.51M 372,255 shares
$6.75
$6.75
Trevi Therapeutics
Trevi Therapeutics TRVI
10% owner
Holding Value $0 0 shares
Last Trade
Apr 17, 2025 Sale (In The Money)Reported as In The Money on SEC Form 4.
$11.2M 1,851,852 shares
$6.07
$17.38
Marker Therapeutics
Marker Therapeutics MRKR
10% owner
Holding Value $2.23M 1,625,678 shares
Last Trade
Dec 23, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.77M 554,250 shares
$3.20
$1.37
NeueHealth
NeueHealth NEUE
10% owner
Holding Value $1.25M 185,594 shares
Last Trade
Oct 01, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$327k 61,865 shares
$5.29
$6.75
NeueHealth
NeueHealth NEUE
10% owner
Holding Value $836k 123,729 shares
Last Trade
Apr 08, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$761k 123,729 shares
$6.15
$6.75
Mirum Pharmaceuticals
Mirum Pharmaceuticals MIRM
10% owner
Holding Value $243M 2,186,243 shares
Last Trade
Jun 13, 2023 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$60.2M 2,000,000 shares
$30.09
$111.07
Akouos
Akouos AKUS
Director
Holding Value $0 0 shares
Last Trade
Nov 30, 2022 Sale (Tender)Reported as Tender on SEC Form 4.
$57.1M 4,294,207 shares
$13.29
$13.29
Genocea Biosciences
Genocea Biosciences GNCA
10% owner
Holding Value $0 0 shares
Last Trade
May 25, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$409k 4,445,093 shares
$0.09
$0.00
Genocea Biosciences
Genocea Biosciences GNCA
10% owner
Holding Value $445 4,445,093 shares
Last Trade
May 24, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$361k 5,931,843 shares
$0.06
$0.00
Trevi Therapeutics
Trevi Therapeutics TRVI
10% owner
Holding Value $181M 10,421,428 shares
Last Trade
Apr 11, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$7.16M 2,631,578 shares
$2.72
$17.38
Trevi Therapeutics
Trevi Therapeutics TRVI
10% owner
Holding Value $181M 10,421,428 shares
Last Trade
Apr 11, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$7.16M 2,631,578 shares
$2.72
$17.38
Metacrine
Metacrine MTCR
10% owner
Holding Value $1.59M 2,734,189 shares
Last Trade
Dec 22, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$446k 459,700 shares
$0.97
$0.58
Metacrine
Metacrine MTCR
10% owner
Holding Value $1.76M 3,022,957 shares
Last Trade
Dec 10, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$49.6k 37,570 shares
$1.32
$0.58

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up